WebDisclosure WebDisclosure
Basculer en Français
9515 Companies
186901 Keywords
119050 Articles
99971 Press releases
Headlines Articles Press releases Indivumed GmbH Remove
  1. Home
  2. Companies
  3. Indivumed GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/10/2025 at 14:10, 1 day 5 hours ago

    Indivumed and University of Rochester expand cancer research collaboration

    Precision Oncology Cancer Research Novel Therapeutics Patient-derived Models Clinical Collaboration
  • BRIEF

    published on 12/10/2025 at 14:10, 1 day 5 hours ago

    Indivumed et l'Université de Rochester étendent leur collaboration en matière de recherche sur le cancer

    Oncologie De Précision Nouvelles Thérapies Recherche Sur Le Cancer Modèles Dérivés De Patients Collaboration Clinique
  • PRESS RELEASE

    published on 12/10/2025 at 14:05, 1 day 6 hours ago

    Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics

    Indivumed partners with University of Rochester Medical Center for patient-centric cancer therapeutics discovery, focusing on precision oncology and advanced stages of solid cancers
    Precision Oncology Cancer Research Indivumed University Of Rochester Therapeutics Discovery
    Logo of Indivumed GmbH
Accesswire
  • Published on 12/11/2025 at 19:30, 37 minutes ago

    Black Titan Announces DAT+ Liquidity and Operational Readiness Pillar to Support Institutional-Grade Digital Asset Engagement

  • Published on 12/11/2025 at 18:30, 1 hour 37 minutes ago

    SMX Keeps Adding Mileage to Its Molecular Empire, and Cotton Is the Latest Proof That the Deal-Making Bonanza Is Real

  • Published on 12/11/2025 at 18:00, 2 hours 7 minutes ago

    Black Titan Introduces DAT+ Collaborative Engagement Pillar to Support High-Value Decentralized Ecosystems

  • Published on 12/11/2025 at 17:40, 2 hours 27 minutes ago

    Accelerating Momentum for NioCorp as Local Residents, Federal and State Leaders Voice Support at Nebraska Town Hall Meeting

  • Published on 12/11/2025 at 17:00, 3 hours 7 minutes ago

    Cotton Just Became a Digital Asset, and SMX Is Building its Market Where Proof Sets the Price

View all ACCESSWIRE
EQS Group
  • Published on 12/11/2025 at 19:05, 1 hour 1 minute ago

    POS-Transaction in Own Shares

  • Published on 12/11/2025 at 18:48, 1 hour 19 minutes ago

    EEII AG: Update on reverse takeover of Jubin Frères S.A.

  • Published on 12/11/2025 at 18:30, 1 hour 37 minutes ago

    911 GT3 90 F. A. Porsche: collector's car in honour of the visionary designer

  • Published on 12/11/2025 at 18:22, 1 hour 44 minutes ago

    EQS-Adhoc: Pyrum Innovations AG completes capital increase with subscription rights against cash contributions from authorized capital

  • Published on 12/11/2025 at 18:00, 2 hours 7 minutes ago

    Hunyvers S.A.: Hunyvers publie ses résultats pour l’ensemble de l’exercice 2024-2025

View all EQS
Les Echos
  • Published on 12/11/2025 at 19:23, 44 minutes ago

    Eiffage is joining the CAC 40 index

  • Published on 12/11/2025 at 19:23, 44 minutes ago

    Eiffage intègre le CAC 40

  • Published on 12/11/2025 at 18:00, 2 hours 7 minutes ago

    GERARD PERRIER INDUSTRIE rachète les sociétés A.Q.L.E, Somalec et Somalec supply

  • Published on 12/11/2025 at 17:45, 2 hours 22 minutes ago

    STEF : Droits de vote au 30-11-2025

  • Published on 12/11/2025 at 14:09, 5 hours 57 minutes ago

    Déclaration d'actions et de droits de vote au 30.11.2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy